Lenmid 5 mg

Lenmid 5 mg Capsule is classified under immunomodulatory agents, with lenalidomide as its active ingredient. This medication is prescribed for adults to manage multiple myeloma, mantle cell lymphoma, myelodysplastic syndromes, and follicular lymphoma. Multiple myeloma is a type of cancer where plasma cells in the bone marrow grow uncontrollably, leading to severe health issues. Though this cancer is incurable, its symptoms can be managed. Myelodysplastic syndromes involve a range of blood and bone marrow disorders where blood cells become abnormal and dysfunctional. Mantle cell lymphoma is a rarer form of cancer that targets the lymph nodes. Follicular lymphoma is a slow-progressing cancer affecting B cells.

Common side effects of Lenmid 5 mg Capsule may include nausea, diarrhea, constipation, muscle cramps, fatigue, fever, cough, headache, back pain, shortness of breath, rashes, and issues related to the thyroid and skin. If any of these side effects become troublesome or persistent, it is essential to consult your doctor.

Before starting treatment with Lenmid 5 mg Capsule, it is crucial to inform your doctor if you have any allergies to the medication or its components. Additionally, discuss your medical history, particularly if you have experienced blood clots, heart attacks, or if you smoke, have high blood pressure, or elevated cholesterol levels. Mention any viral infections such as hepatitis B, varicella zoster, or HIV. Regular blood tests will be necessary before and during treatment, as this medication can cause a reduction in blood cell counts. Lenmid 5 mg Capsule is not recommended for individuals under 18 years of age.